Back to User profile » Dr Hassan Ahmed
Paper published by Dr Hassan Ahmed:
Original Research
![Noteworthy comment: This paper reports on phase II of the study of Ambovex for HCC. It shows promising activity.](assets/img/article_icons/noteworthy.png)
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Ambovex® as a novel immunological modulator drug for the treatment of hepatocellular carcinoma (HCC) in the liver: a Phase II clinical trial
Salama H, Ahmad H, Elchagea I, Zekri AR, Medhat E, Bahnassy A, Lange M, Rabbat M, de la Torre AN, Punamiya P
Journal of Hepatocellular Carcinoma 2015, 2:79-89
Published Date: 22 June 2015